| Literature DB >> 8784887 |
C F Levenback1, G Tortolero-Luna, D K Pandey, A Malpica, V V Baker, L Whittaker, E Johnson, M Follen Mitchell.
Abstract
Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.Entities:
Mesh：
Substances：
Year: 1996 PMID： 8784887
Source DB: PubMed Journal: Obstet Gynecol Clin North Am ISSN： 0889-8545 Impact factor: 2.844